Increased concentrations of endothelin-1 messenger RNA in tissues and endothelin-1 peptide in plasma in septic pigs
- 1 September 1996
- journal article
- Published by Wolters Kluwer Health in Critical Care Medicine
- Vol. 24 (9) , 1530-1536
- https://doi.org/10.1097/00003246-199609000-00017
Abstract
To study the expression of preproendothelin-1 messenger RNA (mRNA) in tissue after Escherichia coli lipopolysaccharide challenge and to evaluate the possible effects of betamethasone both regarding endothelin-1 production as well as hemodynamic and vascular effects during E. coli lipopolysaccharide infusion in pigs in vivo. Prospective trial. Laboratory at a university medical center. Ten domestic pigs, weighing 18 to 25 kg. Anesthetized pigs were given continuous infusions of E. coli lipopolysaccharide (15 micrograms/kg/hr for 3 hrs), with or without prior treatment with betamethasone (0.5 mg/kg im 12 hrs before the start of the surgical preparation and 0.5/kg iv at the start of the preparation). The E. coli lipopolysaccharide infusion evoked the characteristic cardiovascular changes observed in septic shock: decreased mean arterial pressure and cardiac output; increased heart rate and increased pulmonary vascular resistance. Large increases in both arterial plasma concentrations of endothelin-1-like immunoreactivity, as well as preproendothelin-1 mRNA concentrations in tissues, were also observed during the E. coli lipopolysaccharide infusion. Treatment with betamethasone significantly attenuated the E. coli lipopolysaccharide-induced increase in endothelin-1 plasma concentrations, whereas the increased mRNA concentrations were only slightly affected. Furthermore, betamethasone treatment also affected cardiovascular parameters, with significant attenuation of the E. coli lipopolysaccharide-induced increase in heart rate and a higher cardiac output after 60 mins of the E. coli lipopolysaccharide infusion. The urine production, which was markedly decreased during the E. coli lipopolysaccharide infusion, was significantly higher in the betamethasone-treated group compared with the control group. The present results indicate that the increased concentrations of endothelin-1-like immunoreactivity that are observed in septic shock may have negative effects on both cardiovascular parameters as well as renal function, which is in agreement with a possible role for endothelin-1 in the pathogenesis of septic shock.Keywords
This publication has 26 references indexed in Scilit:
- Circulating and Tissue Endothelin Immunoreactivity in Advanced AtherosclerosisNew England Journal of Medicine, 1991
- Endothelin-like immunoreactivity in rat models of diabetes mellitusJournal of Endocrinology, 1991
- Glucocorticoids induce endothelin release from vascular smooth muscle cells but not endothelial cellsEuropean Journal of Pharmacology, 1991
- Elevated Plasma Endothelin-1 Concentrations Are Associated with the Severity of Illness in Patients with SepsisAnnals of Surgery, 1991
- Release of endothelin‐like immunoreactivity in relation to neuropeptide Y and catecholamines during endotoxin shock and asphyxia in the pigActa Physiologica Scandinavica, 1990
- Cytokine-induced release of endothelin-1 from porcine renal epithelial cell lineBiochemical and Biophysical Research Communications, 1990
- Increased plasma levels of endothelin‐like immunoreactivity during endotoxin administration in the pigActa Physiologica Scandinavica, 1989
- INCREASED PLASMA CONCENTRATIONS OF ENDOTHELIN-1 AND BIG ENDOTHELIN-1 IN ACUTE MYOCARDIAL INFARCTIONThe Lancet, 1989
- Endotoxin stimulates endothelin-release in vivo and in vitro as determined by radioimmunoassayBiochemical and Biophysical Research Communications, 1989
- A novel potent vasoconstrictor peptide produced by vascular endothelial cellsNature, 1988